Doogan Declan — SEC insider filings
SEC reporting owner CIK 1704234. 13 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2021-05-07 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 53,000 shares, $101,760 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 13 legs across 4 filings — 154,524 shares, $13,319,592 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 18,230 shares @ $116.69 ($2,127,173) in Biohaven Pharmaceutical Holding Co Ltd., filed 2021-11-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Director | 5 | — | 13 legs · 154,524 sh · $13,319,592 | 15 |
| TENAX THERAPEUTICS, INC. (TENX) | Director | 8 | 1 leg · 53,000 sh · $101,760 | — | 10 |
Insider filings — Doogan Declan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Purchase (P): 53,000 @ $1.92 | EDGAR |
| 2026-01-13 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-08-12 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Gift (G): 567,871 @ $0 · Gift (G): 567,871 @ $0 | EDGAR |
| 2022-06-10 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4/A | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Sale (S): 11,706 @ $64.42 · Sale (S): 13,333 @ $64.71 · Sale (S): 12,580 @ $65.55 · Sale (S): 13,334 @ $66.01 | EDGAR |
| 2022-02-11 | 4/A | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Sale (S): 2,464 @ $67.83 · Sale (S): 13,334 @ $68.15 · Sale (S): 15,508 @ $68.58 · Sale (S): 10,000 @ $68.97 | EDGAR |
| 2021-12-01 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Sale (S): 13,026 @ $112.40 · Sale (S): 11,499 @ $113.25 | EDGAR |
| 2021-11-17 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 250,000 @ $0.61 · Option exercise (M): 175,000 @ $5.60 · Option exercise (M): 50,000 @ $9.29 · Option exercise (M): 18,000 @ $28.76 · Option exercise (M): 18,000 @ $61.76 · Option exercise (M): 30,000 @ $10.82 · +11 more | EDGAR |
| 2021-08-11 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Gift (G): 567,871 @ $0 | EDGAR |
| 2021-06-15 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Option exercise (M): 3,070,000 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 3,070 (derivative) | EDGAR |
| 2021-05-07 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Grant/award (A): 11,996 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1704234 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs